Democratising access to genetic services
Related Experiment Video
Updated: Aug 10, 2026

FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
Bryn Williams-Jones1, Michael M Burgess
1Cardiff Institute of Society, Health and Ethics, Cardiff University, 53 Park Place, Cardiff, Wales, United Kingdom. bryn.williams-jones@umontreal.ca
Abstract:
Professional and policy discussions about the appropriate funding and allocation of health cares services are an essential part of the management of public and private health care insurance plans. However, the ability of governments and health professionals to equitably decide on the distribution of health care is being challenged by the increasing drive to patent health care technologies. Referring to the case of genetic testing for hereditary breast cancer (and Myriad Genetics' patenting of the BRCA1 & BRCA2 genes), this paper applies some concepts from moral philosophy to think through the effects of the commercialisation of genetic technologies, and what would constitute a more just and rational approach to health care decision-making, in the context of the Canadian health insurance system.
More Related Videos
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
What is Genetic Engineering?
Pharmacogenomics: Identification of New Drug Targets
Animal Mitochondrial Genetics
The Central Dogma
RNA is the Missing Link Between DNA and Proteins
In the early 1900s, scientists discovered that DNA stores all the information needed for cellular functions and that proteins perform most of these functions. However, the mechanisms of converting genetic information into functional proteins remained unknown for many years. Initially, it was believed that a single gene is...
CRISPR

